Healthcare / Medical Care FacilitiesTaipei Exchange
$140.00
+2.00 (+1.45%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $1.1B · quality 84.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
51/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$11.9B
P/E
11.4x
↓EV/EBITDA
6.3x
↓ROE
25.9%
↑Gross Margin
59.1%
↑Debt/Equity
0.26
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+6.4%
FCF CAGR
+12.5%
FCF margin
26.2%
FCF / Net income
1.06x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $4.20B · net income $1.04B · FCF $1.10B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.20B | $4.20B | $4.23B | $4.08B | $3.49B |
| Net Income | $1.04B | $1.04B | $1.06B | $1.05B | $850.5M |
| EBITDA | $1.91B | $1.91B | $1.86B | $1.78B | $1.48B |
| EPS | — | — | 12.53 | 12.31 | 10.02 |
| Gross Margin | 59.1% | 59.1% | 59.9% | 60.0% | 61.2% |
| Operating Margin | 32.8% | 32.8% | 33.1% | 32.2% | 31.2% |
| Net Margin | 24.8% | 24.8% | 25.2% | 25.6% | 24.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.26 | 0.26 | 0.29 | 0.24 | 0.29 |
| Current Ratio | 1.91 | 1.91 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.10B | $1.10B | $1.23B | $1.08B | $775.3M |
| Returns | |||||
| ROE | 25.9% | 25.9% | 29.4% | 32.9% | 31.9% |
| Valuation | |||||
| P/E | 11.43 | 11.43 | 15.96 | 22.38 | 29.00 |
| EV/EBITDA | 6.34 | 6.34 | 9.43 | 12.98 | 16.74 |
| P/B | 2.95 | 2.95 | 4.69 | 7.36 | 9.25 |
| Growth & Yield | |||||
| Revenue Growth | -0.6% | -0.6% | 3.6% | 16.8% | — |
| EPS Growth | — | — | 1.8% | 22.9% | — |
| Dividend Yield | 5.5% | 5.5% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-26.5%
Start / end P/E
n/dx → n/dx
EPS bridge
12.53 → n/d
Residual
-32.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.